Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autosomal-dominant primary immunodeficiencies.

Tatiana Lawrence1, Anne Puel, Janine Reichenbach

  • 1Laboratory of Human Genetics of Infectious Diseases, University of Paris, René Descartes INSERM U550, Paris, France.

Current Opinion in Hematology
|December 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BIRC3 (Encoding Cellular Inhibitor of Apoptosis Protein 2) Variants Result in Dysregulated Receptor-Interacting Protein Kinase 1 Signaling Leading to Increased Epithelial Cell Death and Are Associated With Monogenic Crohn's Disease.

Gastroenterology·2026
Same author

Chronic granulomatous disease: Clinical, microbial, and genetic findings in 39 Colombian patients.

Journal of human immunity·2026
Same author

Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections.

Cell·2026
Same author

High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons.

The Journal of infectious diseases·2026
Same author

Inherited human CARD9 deficiency impairs lymphoid cell, but not fibroblast, IL-17-mediated immunity.

JCI insight·2026
Same author

Anti-granulocyte macrophage colony-stimulating factor autoantibodies: A rising cause of infectious diseases.

PLoS pathogens·2026
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Autosomal-dominant primary immunodeficiencies (PIDs) are rare but increasingly identified. Recent studies reveal novel PIDs caused by mutations in genes like ELA2, CXCR4, and STAT1, expanding our understanding of immune system genetics.

Area of Science:

  • Immunology
  • Genetics
  • Human Disease

Background:

  • Most primary immunodeficiencies (PIDs) follow autosomal or X-linked recessive inheritance.
  • Autosomal-dominant PIDs are rare, with only four classical types known, and three lacking clear genetic causes.
  • Syndromes like Di George suggest dominant, non-Mendelian inheritance patterns.

Purpose of the Study:

  • To review recent advances in identifying and characterizing autosomal-dominant PIDs.
  • To highlight novel genetic etiologies for primary immunodeficiencies.

Main Methods:

  • Review of recent clinical and genetic studies on autosomal-dominant PIDs.
  • Identification of genes associated with newly described autosomal-dominant PIDs.

Main Results:

Related Experiment Videos

  • Six novel autosomal-dominant PIDs have been described recently.
  • Germline mutations in seven genes (ELA2, GFI1, CXCR4, LCRR8, IFNGR1, STAT1, IKBA) are linked to these PIDs.
  • Specific mutations are associated with conditions including congenital neutropenia, warts, hypogammaglobulinemia, infections, myelokathexis syndrome, agammaglobulinemia, mycobacterial diseases, and ectodermal dysplasia with immunodeficiency.

Conclusions:

  • The landscape of autosomal-dominant PIDs is expanding rapidly.
  • Further identification of autosomal-dominant PIDs is anticipated in the near future.
  • Understanding these genetic defects is crucial for diagnosis and potential therapeutic strategies.